August 2020 Briefing – Radiology

Here are what the editors at HealthDay consider to be the most important developments in Radiology for August 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

AI Model Using Chest X-Ray May Predict 12-Year Lung Cancer Risk

MONDAY, Aug. 31, 2020 (HealthDay News) — A deep learning model based on chest radiograph (CXR) images and data from the electronic medical record (EMR) has better discrimination for smokers at high risk for incident lung cancer than Centers for Medicare & Medicaid Services (CMS) eligibility, according to a study published online Sept. 1 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Delayed Radiotherapy Not Tied to Worse Survival in Prostate Cancer

FRIDAY, Aug. 14, 2020 (HealthDay News) — For men with prostate cancer (PC), initiation of radiotherapy (RT) up to six months after androgen deprivation therapy (ADT) is not associated with worse overall survival (OS), according to a research letter published online Aug. 13 in JAMA Oncology.

Abstract/Full Text

MASCC/ISOO Update Guidelines for Management of Mucositis

MONDAY, Aug. 31, 2020 (HealthDay News) — The Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology (MASCC/ISOO) have issued updated recommendations for the management of mucositis; a summary of these updates was published online July 28 in Cancer.

Abstract/Full Text

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Aug. 24 to 28, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.

Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article

No SARS-CoV-2 RNA Seen on Surfaces in Radiation Oncology Clinic

THURSDAY, Aug. 27, 2020 (HealthDay News) — Testing of environmental surfaces in the radiation oncology clinic in a tertiary care COVID-19 referral center revealed no detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA, according to a research letter published online Aug. 27 in JAMA Oncology.

Abstract/Full Text

Survival Worse for Breast Cancers Secondary to Childhood Cancer